LINEAGE CELL THERAPEUTICS IN

Ticker: LCTX CUSIP: 53566P109 Class: COM

Crewe Advisors LLC's Holding History (CIK: 0001730033)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 1,016 Value ($000) $1 Avg Close $1.10 Range $0.84 - $1.56
Q1 2024
Shares 1,016 Value ($000) $2 Avg Close $1.13 Range $0.84 - $1.61